Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Hakendorf is active.

Publication


Featured researches published by Paul Hakendorf.


Internal Medicine Journal | 2001

Scleroderma in South Australia: epidemiological observations of possible pathogenic significance

P. J. Roberts-Thomson; M. Jones; Paul Hakendorf; A. A. S. S. Kencana Dharmapatni; Jenny Walker; J. G. Macfarlane; Malcolm D. Smith; M. J. Ahern

Background: Scleroderma is an autoimmune disorder of unknown cause. Previous epidemiological studies have suggested some regional clustering and associations with occupations involving exposure to silica dusts and hydrocarbons.


International Journal of Rheumatic Diseases | 2012

South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome

Scott W. Graf; Paul Hakendorf; Susan Lester; Karen Patterson; Jenny Walker; Malcolm D. Smith; M. J. Ahern; P. J. Roberts-Thomson

Aim:  To investigate the relationship between scleroderma‐specific autoantibodies and clinical phenotype and survival in South Australian patients with scleroderma.


Internal Medicine Journal | 2011

Survival in scleroderma: results from the population‐based South Australian Register

P Hissaria; S. Lester; Paul Hakendorf; Richard J. Woodman; Karen Patterson; Catherine Hill; M. J. Ahern; Malcolm D. Smith; Jennifer G. Walker; P. J. Roberts-Thomson

Aim:  To ascertain the mortality risk and investigate clinical and serological factors influencing survival of patients listed on the South Australian Scleroderma Register (SASR).


International Journal of Rheumatic Diseases | 2013

Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases

Ju Ann Tan; P. J. Roberts-Thomson; Peter C. Blumbergs; Paul Hakendorf; Sally Cox; Vidya Limaye

Aim:  To describe the epidemiology of biopsy‐proven idiopathic inflammatory myopathies (IIM) in South Australia (SA).


Internal Medicine Journal | 2006

Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation

P. J. Roberts-Thomson; Jennifer G. Walker; Tim Yu-Ting Lu; Adrian Esterman; Paul Hakendorf; Malcolm D. Smith; M. J. Ahern

Background: The aim of this study was to determine the incidence, prevalence, survival and selective demographic characteristics of scleroderma occurring in South Australia over the 10‐year period 1993–2002.


Internal Medicine Journal | 2012

Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis.

Vidya Limaye; Paul Hakendorf; Richard J. Woodman; Peter C. Blumbergs; P. J. Roberts-Thomson

Background:  There is a paucity of literature on the patterns and predictors of mortality in idiopathic inflammatory myopathies (IIM).


Arthritis & Rheumatism | 2015

Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis

Kevin Patterson; P. J. Roberts-Thomson; S. Lester; Juann Tan; Paul Hakendorf; Maureen Rischmueller; Jane Zochling; Joanne Sahhar; Peter Nash; Janet Roddy; Catherine Hill; Mandana Nikpour; Wendy Stevens; Susanna Proudman; Jennifer G. Walker

To determine the relationships between systemic sclerosis (SSc)–related autoantibodies, as well as their clinical associations, in a well‐characterized Australian patient cohort.


Internal Medicine Journal | 2013

Characteristics and outcomes of discharges against medical advice among hospitalised patients

Tuck Y. Yong; Jie Shen Fok; Paul Hakendorf; David I. Ben-Tovim; Campbell H. Thompson; Jordan Yz Li

Discharge against medical advice (DAMA) occurs when an in‐patient chooses to leave the hospital before discharge is recommended by the treating clinicians. The long‐term outcomes of patients who DAMA are not well documented.


Geriatrics & Gerontology International | 2012

Medication prescription among elderly patients admitted through an acute assessment unit

Tuck Y. Yong; Su Yin Lau; Jordan Yuanzhi Li; Paul Hakendorf; Campbell H. Thompson

Aim:  This study assessed medication use patterns and polypharmacy in patients who were admitted through an acute assessment unit (AAU) and stratified results according to patient age. This study also examined risk factors associated with polypharmacy and consequences of polypharmacy, namely prescription writing errors, drug–drug interaction and geriatric syndrome.


Anz Journal of Surgery | 2004

Adhesional small bowel obstruction after colorectal surgery

Matthew D. Ryan; David Wattchow; Margaret Walker; Paul Hakendorf

Background:  Acute clinical indicators of complications in colorectal surgery can be readily attained but it is much harder to gather indicators of long‐term outcomes such as small bowel obstruction (SBO). However, with improved in‐hospital data collection and coding such information is becoming available. The aim of the present study was to examine our own hospital database for SBO rates post‐colorectal surgery.

Collaboration


Dive into the Paul Hakendorf's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tuck Y. Yong

Flinders Medical Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge